NEW YORK, Oct. 7, 2014 /PRNewswire/ -- Harwood Feffer
LLP (www.hfesq.com) is investigating potential claims against the
board of directors of AcelRx Pharmaceuticals, Inc. ("AcelRx" or the
"Company") (NASDAQ: ACRX), concerning whether the board has
breached its fiduciary duties to shareholders.
One of AcelRx's products is called Zalviso. Zalviso is a
pain management system consisting of tablets delivered by a
needle-free, handheld, patient-administered technique. On
July 25, 2014, after the market
closed, AcelRx announced that it had received a Complete Response
Letter from the U.S. Food and Drug Administration ("FDA") regarding
its New Drug Application for Zalviso. The FDA requested additional
information on the Zalviso System to ensure proper use of the
device, including changes to the Instructions for Use for the
device and additional data to support the shelf life of the
product.
Our investigation concerns whether the Company board of
directors has breached its fiduciary duties to shareholders,
grossly mismanaged the Company, and/or committed abuses of control
in connection with the foregoing.
If you own AcelRx shares and wish to discuss this matter with
us, or have any questions concerning your rights and interests with
regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212) 935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been
representing individual and institutional investors for many years,
serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website
(http://www.hfesq.com) for more information about the
firm.
Attorney Advertising. The law firm responsible for this
advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results
do not guarantee or predict a similar outcome with respect to any
future matter.
Logo -
http://photos.prnewswire.com/prnh/20120215/MM54604LOGO
SOURCE Harwood Feffer LLP